Descrizione business
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses.
Consiglio di amministrazione & Consiglio di sorveglianza
| CEO |
| Charles Kummeth |
| Consiglio di amministrazione |
| Jim Hippel, Kim Kelderman, Will Geist, Shane Bohnen, Peter Breloer, Qi Cheng, Steve Crouse, Brenda S. Everson, Bob Gavin, Lynne Hohlfeld, Evett Kruka, Steven Silverman, Kevin Smyth, Peter Schuessler |
| Consiglio di sorveglianza |
| Robert V. Baumgartner, Charles Kummeth, Dr. Alpna Seth, Dr. Joseph D. Keegan, Dr. Randolph C. Steer, Dr. Roland Nusse, Dr. Rupert Vessey, John L. Higgins, Julie L. Bushman |
Dati aziendali
| Name: |
Bio-Techne Corp. |
| Indirizzo: |
614 McKinley Place N.E.,Minneapolis, MN 55413, USA |
| Telefono: |
+1-612-379-2956 |
| Fax: |
+1-612-656-4400 |
| E-mail: |
info@bio-techne.com
|
| Internet: |
bio-techne.com/ |
| Industria: |
Healthcare |
| Settore: |
Medical Products |
| Sub settore: |
Advanced Medical Devices |
| Fine dell'anno finanziario: |
30/06 |
| Flottante libero: |
79.40% |
| Data dell'IPO: |
08/05/1989 |
Rapporti con gli investitori
| Name: |
David Clair |
| IR telefono: |
+1-612-656-4416 |
| IR Fax: |
- |
| IR e-mail: |
ir@bio-techne.com
|
